Diffusion tensor MR imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities

BackgroundNeurofibromatosis type 1 (NF1) is a hereditary disease with a dominant autosomal pattern. In children and adolescents, it is frequently associated with the appearance of T2-weighted hyperintensities in the brain’s white matter. MRI with diffusion tensor imaging (DTI) is used to detect white matter abnormalities by measuring fractional anisotropy (FA).ObjectiveThis study employed DTI to evaluate the relationship between FA patterns and the findings of T2 sequences, with the aim of improving our understanding of anatomical changes and microstructural brain abnormalities in individuals with NF1.Materials and methodsForty-four individuals with NF1 and 20 control subjects were evaluated. The comparative analysis of FA between NF1 and control groups was based on four predetermined anatomical regions of the brain hemispheres (basal ganglia, cerebellum, pons, thalamus) and related the presence or absence of T2-weighted hyperintensities in the brain, which are called unidentified bright objects (UBOs).ResultsThe FA values between the groups demonstrated statistically significant differences (P ≤ 0.05) for the cerebellum and thalamus in patients with NF1, independent of the occurrence of UBOs.ConclusionsDiffusion tensor MR imaging confirms the influence of UBOs in the decrease of FA values in this series of patients with NF1. Additionally, this technique allows the characterization of microstructural abnormalities even in some brain regions that appear normal in conventional MR sequences.

[1]  H J Koch,et al.  A randomized controlled trial of prednisone in Alzheimer’s disease , 2000, Neurology.

[2]  R. Bryan,et al.  Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. , 1994, AJNR. American journal of neuroradiology.

[3]  K. Sartor,et al.  High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis. , 1989, AJNR. American journal of neuroradiology.

[4]  A. Barkovich,et al.  Evolution of white matter lesions in neurofibromatosis type 1: MR findings. , 1992, AJR. American journal of roentgenology.

[5]  C. Catsman-Berrevoets,et al.  Quantitative Differentiation Between Healthy and Disordered Brain Matter in Patients with Neurofibromatosis Type I Using Diffusion Tensor Imaging , 2008, American Journal of Neuroradiology.

[6]  E. Zackai,et al.  Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. , 1995, Radiology.

[7]  A. Barkovich,et al.  Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1. , 1996, AJNR. American journal of neuroradiology.

[8]  Leonard E White,et al.  Diffusion tensor imaging assessment of brain white matter maturation during the first postnatal year. , 2007, AJR. American journal of roentgenology.

[9]  B. Katz Neurofibromatosis: Phenotype, Natural History and Pathogenesis , 2001 .

[10]  Jun Hatazawa,et al.  Practical visualization of internal structure of white matter for image interpretation: staining a spin-echo T2-weighted image with three echo-planar diffusion-weighted images. , 2003, AJNR. American journal of neuroradiology.

[11]  A. Alexander,et al.  Diffusion tensor imaging of cerebral white matter: a pictorial review of physics, fiber tract anatomy, and tumor imaging patterns. , 2004, AJNR. American journal of neuroradiology.

[12]  D. Mikulis,et al.  Tumor Effects on Cerebral White Matter as Characterized by Diffusion Tensor Tractography , 2007, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[13]  K A Il'yasov,et al.  Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1. , 2007, AJNR. American journal of neuroradiology.

[14]  J. Friedman,et al.  Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children , 2000, Neurology.

[15]  G. Ramsby,et al.  Magnetic resonance imaging lesion analysis in neurofibromatosis type 1. , 1998, Archives of neurology.

[16]  J. Friedman,et al.  Unidentified bright objects associated with features of neurofibromatosis 1. , 2002, Pediatric neurology.

[17]  M. Kaiser-Kupfer,et al.  NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. , 1990, Annals of internal medicine.

[18]  M. Kraut,et al.  Longitudinal evolution of unidentified bright objects in children with neurofibromatosis‐1 , 2004, American journal of medical genetics. Part A.

[19]  É. Pavarino-Bertelli,et al.  Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1 , 2008, Pediatric Radiology.

[20]  Carl-Fredrik Westin,et al.  High-resolution line scan diffusion tensor MR imaging of white matter fiber tract anatomy. , 2002, AJNR. American journal of neuroradiology.

[21]  J. Szudek,et al.  Use of the National Institutes of Health Criteria for Diagnosis of Neurofibromatosis 1 in Children , 2000, Pediatrics.

[22]  W. Kaiser,et al.  Pediatric brain MRI in neurofibromatosis type I , 2005, European Radiology.